Table 2 Breakdown of pSoBid study subjects

LD Female

35–44

55 (30.4%)

2 (1%)

66 (36.5%)

58 (32.1%)

181 (100%)

LD Female

45–54

56 (31.5%)

4 (2.2%)

74 (41.6%)

44 (24.7%)

178 (100%)

LD Female

55–64

60 (49.2%)

1 (0.8%)

46 (37.7%)

15 (12.3%)

122 (100%)

LD Female

Total

171 (35.6%)

7 (1.4%)

186 (38.7%)

117 (24.3%)

481 (100%)

LD Male

35–44

52 (21.6%)

2 (0.8%)

74 (30.7%)

113 (46.9%)

241 (100%)

LD Male

45–54

58 (34.7%)

1 (0.6%)

51 (30.6%)

57 (34.1%)

167 (100%)

LD Male

55–64

61 (51.2%)

2 (1.7%)

31 (26.1%)

25 (21.0%)

119 (100%)

LD Male

Total

171 (32.4%)

5 (1%)

156 (29.6%)

195 (37.0%)

527 (100%)

LD Participants

342 (33.9%)

12 (1.2%)

342 (33.9%)

312 (31%)

1008 (100%)

MD Female

35–44

55 (17.3%)

6 (1.9%)

70 (22.0%)

187 (58.8%)

318 (100%)

MD Female

45–54

55 (26%)

5 (2.4%)

69 (32.7%)

82 (38.9%)

211 (100%)

MD Female

55–64

58 (27.2%)

2 (1%)

81 (38.0%)

72 (33.8%)

213 (100%)

MD Female

Total

168 (22.6%)

13 (1.8%)

220 (29.6%)

341 (46.0%)

742 (100%)

MD Male

35–44

49 (13.6%)

2 (0.5%)

56 (15.5%)

254 (70.4%)

361 (100%)

MD Male

45–54

53 (16.5%)

4 (1.3%)

79 (24.6%)

185 (57.6%)

321 (100%)

MD Male

55–64

54 (19.3%)

3 (1.1%)

115 (41.0%)

108 (38.6%)

280 (100%)

MD Male

Total

156 (16.2%)

9 (0.9%)

250 (26.0%)

547 (56.9%)

962 (100%)

MD Participants

324 (19.0%)

22 (1.3%)

470 (27.6%)

888 (52.1%)

1704 (100%)

GRAND

TOTAL

666 (24.6%)

34 (1.3%)

812 (29.9%)

1,200 (44.2%)

2712 (100%)